SightfileU.S. market data from official filings

INNOVIVA INC (INVA)

Name: INNOVIVA INC (INVA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001080014 · EDGAR filings · Updated 2026-05-22

INNOVIVA INC (INVA) has reported institutional ownership of 101.8%, with 284 institutional managers holding positions valued at $1.75B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

101.8%

Institutional managers

284

Reported 13F value

$1.75B

Insider activity

18 trans.

$0 net flat

Data flags

2 active

from SEC filings

Latest updates

2026-05-22 — Insider transaction reported (Form 4)
2026-05-22 — Insider transaction reported (Form 4)
2026-05-22 — Insider transaction reported (Form 4)
2026-05-20 — Insider transaction reported (Form 4)
2026-05-20 — Initial insider ownership filed (Form 3)
2026-05-18 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INNOVIVA INC has 284 institutional holders and institutional ownership of 101.8%.

Insider activity

Insiders reported 18 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-27 (recurring since 2022-03-17) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-08-07 (recurring since 2023-08-07) — source filing. The authoritative details are those stated in the filing itself.

Related companies

OCULAR THERAPEUTIX INC (OCUL) · PEDIATRIX MEDICAL GROUP INC (MD) · ZYMEWORKS INC (ZYME) · LEGEND BIOTECH CORP (LEGN) · UFP TECHNOLOGIES INC (UFPT) · DR REDDYS LABS LTD (RDY)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-05-22.